Sara Hurvitz, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Arvinas, Astra Zeneca, Bayer, Celcuity, Cytomx, Daiichi-Sankyo, Dantari, Dignitana, Genentech/Roche, G1-Therapeutics, Gilead, Greenwich Life Sciences Inc, GSK, Immunomedics, Eli Lilly, Macrogenics, Novartis, OBI Pharma, Orinove, Orum, Pfizer
    Topic:
    Breast Cancer Trials
    Date added:
    10/28/2023
    Date updated:
    10/28/2023
    Relationship end date:
    07/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Phoenix Molecular Designs, Ltd., Pieris, PUMA, Radius, Samumed, Sanofi, Seattle Genetics/Seagen, Zymeworks
    Topic:
    Breast Cancer Trials
    Date added:
    10/28/2023
    Date updated:
    10/28/2023
    Relationship end date:
    07/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Dantari, LOXO
    Topic:
    Breast Cancer Trials
    Date added:
    10/28/2023
    Date updated:
    10/28/2023
    Relationship end date:
    07/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Onclive, Curio
    Topic:
    Education
    Date added:
    10/28/2023
    Date updated:
    10/28/2023
Return to Best of ASH & SABCS 2024, Seattle